InsidersTradesSigma
지에프씨생명과학: directors' dealings · South Korea · DART (FSS)
DART:company-8787f2KR·DART (FSS)Mcap 43.5Bn€Healthcare
Explore the full directors' dealings record of 지에프씨생명과학, a listed equity based in South Korea. Shares are listed on KR KR, under the supervision of DART (FSS). Operating in the Healthcare sector, 지에프씨생명과학 has published 4 insider filings. Market capitalisation: €43.5bn. The latest transaction was filed on 8 April 2026 — Purchase. Among the most active insiders: 강희철. The full history is openly available.
4
Insider Decl.
0
Thresholds
€2m
3 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
8300.00 €
Analyst consensus
Income statement
Revenue17.71 Bn€
Gross profit8.51 Bn€48% margin
Net income555.4 M€3.1% margin
Valuation
Beta0.98
Balance sheet & cash
Market cap43.50 Bn€
Total debt7.52 Bn€
Free Cash Flow−6.34 Bn€
Debt / Equity32%
Profitability & ownership
ROE3.2%
ROA0.9%
% insiders35.5%
% institutions10.2%
Last declaration on 8 April 2026
Declarations4 total
Executives●Other0DART
DART:20260306000919·details not loaded
4 of 4 declarations